Snowflake Inc
For the period ended Apr 30, 2025. Filed May 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2025 · Filed May 30, 2025
SNOW$295.76+1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| Three Months Ended April 30, 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Treasury Stock · Additional Paid-inCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total Snowflake Inc. Stockholders’ Equity · Noncontrolling Interest · TotalStockholders’Equity | ||||||||||
| Shares · Amount · Shares · Amount | ||||||||||
| BALANCE—January 31, 2025 | 334,301 | $34 | (436) | $(59,505) | $10,355,211 | $(2,236) | $(7,293,575) | $2,999,929 | $6,714 | $3,006,643 |
| Issuance of common stock upon exercise of stock options | 847 | — | — | — | 6,218 | — | — | 6,218 | — | 6,218 |
| Issuance of common stock under employee stock purchase plan | 554 | — | — | — | 53,193 | — | — | 53,193 | — | 53,193 |
| Vesting of restricted stock units | 2,415 | — | — | — | — | — | — | — | — | — |
| Shares withheld related to net share settlement of equity awards | (839) | — | — | — | (131,334) | — | — | (131,334) | — | (131,334) |
| Repurchases and retirement of common stock, including transaction costs and excise tax | (3,214) | — | — | — | — | — | (490,840) | (490,840) | — | (490,840) |
| Reissuance of treasury stock upon settlement of equity awards | — | — | 10 | 1,352 | (1,352) | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 390,519 | — | — | 390,519 | — | 390,519 |
| Other comprehensive income | — | — | — | — | — | 10,407 | — | 10,407 | — | 10,407 |
| Net income (loss) | — | — | — | — | — | — | (430,092) | (430,092) | 140 | (429,952) |
| BALANCE—April 30, 2025 | 334,064 | $34 | (426) | $(58,153) | $10,672,455 | $8,171 | $(8,214,507) | $2,408,000 | $6,854 | $2,414,854 |
| Three Months Ended April 30, 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Treasury Stock · Additional Paid-inCapital · AccumulatedOtherComprehensiveLoss · AccumulatedDeficit · Total Snowflake Inc. Stockholders’ Equity · Noncontrolling Interest · TotalStockholders’Equity | ||||||||||
| Shares · Amount · Shares · Amount | ||||||||||
| BALANCE—January 31, 2024 | 334,453 | $34 | (492) | $(67,140) | $9,331,238 | $(8,220) | $(4,075,604) | $5,180,308 | $10,286 | $5,190,594 |
| Issuance of common stock upon exercise of stock options | 1,370 | — | — | — | 10,517 | — | — | 10,517 | — | 10,517 |
| Issuance of common stock under employee stock purchase plan | 346 | — | — | — | 46,735 | — | — | 46,735 | — | 46,735 |
| Issuance of common stock in connection with a business combination | 1 | — | — | — | — | — | — | — | — | — |
| Vesting of restricted stock units | 3,188 | — | — | — | — | — | — | — | — | — |
| Shares withheld related to net share settlement of equity awards | (1,112) | — | — | — | (177,084) | — | — | (177,084) | — | (177,084) |
| Repurchases and retirement of common stock, including transaction costs | (2,982) | — | — | — | — | — | (516,329) | (516,329) | — | (516,329) |
| Reissuance of treasury stock upon settlement of equity awards | — | — | 23 | 3,182 | (3,101) | — | — | 81 | — | 81 |
| Stock-based compensation | — | — | — | — | 338,487 | — | — | 338,487 | — | 338,487 |
| Other comprehensive loss | — | — | — | — | — | (7,493) | — | (7,493) | — | (7,493) |
| Net loss | — | — | — | — | — | — | (316,988) | (316,988) | (828) | (317,816) |
| BALANCE—April 30, 2024 | 335,264 | $34 | (469) | $(63,958) | $9,546,792 | $(15,713) | $(4,908,921) | $4,558,234 | $9,458 | $4,567,692 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.